Clorox offers investors a compelling yield and a reliable dividend backed by a growing business. With higher valuations across the market, fewer companies can check all three boxes, making Clorox a standout buy in December.

Dividend stocks remain appealing even to wealthy investors who don't rely on income. AbbVie, Johnson & Johnson, and Pfizer are highlighted as strong options for dividend-seeking investors. AbbVie offers a forward dividend yield of nearly 3% and a 52-year streak of increases,

It's been a great couple of years for the stock market. From the end of 2022 through Nov. 29, the benchmark S&P 500 (SNPINDEX: ^GSPC) index rose a whopping 57.1% higher. During this bull run, stock prices have bounded forward much further than earnings from their underlying businesses.